Potential for Gut Peptide-Based Therapy in Postprandial Hypotension

Nutrients. 2021 Aug 17;13(8):2826. doi: 10.3390/nu13082826.

Abstract

Postprandial hypotension (PPH) is an important and under-recognised disorder resulting from inadequate compensatory cardiovascular responses to meal-induced splanchnic blood pooling. Current approaches to management are suboptimal. Recent studies have established that the cardiovascular response to a meal is modulated profoundly by gastrointestinal factors, including the type and caloric content of ingested meals, rate of gastric emptying, and small intestinal transit and absorption of nutrients. The small intestine represents the major site of nutrient-gut interactions and associated neurohormonal responses, including secretion of glucagon-like peptide-1, glucose-dependent insulinotropic peptide and somatostatin, which exert pleotropic actions relevant to the postprandial haemodynamic profile. This review summarises knowledge relating to the role of these gut peptides in the cardiovascular response to a meal and their potential application to the management of PPH.

Keywords: autonomic failure; diabetes mellitus; glucagon-like peptide-1; glucose-dependent insulinotropic polypeptide; postprandial hypotension; somatostatin.

Publication types

  • Review

MeSH terms

  • Acarbose / pharmacology
  • Acarbose / therapeutic use
  • Blood Glucose / metabolism
  • Blood Pressure*
  • Diabetes Mellitus, Type 2 / blood
  • Gastric Inhibitory Polypeptide / blood*
  • Gastrointestinal Agents / pharmacology*
  • Gastrointestinal Agents / therapeutic use
  • Glucagon / blood
  • Glucagon-Like Peptide 1 / blood*
  • Glucagon-Like Peptide-1 Receptor / blood
  • Humans
  • Hypotension* / drug therapy
  • Hypotension* / physiopathology
  • Insulin / blood
  • Peptides
  • Postprandial Period*
  • Somatostatin / blood*
  • Splanchnic Circulation

Substances

  • Blood Glucose
  • Gastrointestinal Agents
  • Glucagon-Like Peptide-1 Receptor
  • Insulin
  • Peptides
  • Somatostatin
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptide 1
  • Glucagon
  • Acarbose